Northern Ireland's Almac Opens CRO Offices In Japan, Singapore
This article was originally published in PharmAsia News
Executive Summary
Almac, a Northern Ireland drug maker, has opened offices in Japan and Singapore, it said, to meet increasing demand for its drug testing and develop services, including management of clinical trials.